Search Results - "эплеренон"

The role of free radical oxidation in the kidneys in the nephroprotective action of eplerenone, a mineralocorticoid receptor antagonist, in experimental diabetes mellitus

A. Yu. Zharikov, S. O. Filinova, O. N. Mazko, O. G. Makarova, I. P. Bobrov, V. M. Bryukhanov

electronic resource

View item; View item; View item

In the wake of the latest clinical guidelines - mineralocorticoid receptor antagonists in the treatment of chronic heart failure

I. V. Zhirov, Y. F. Osmolovskaya, S. N. Tereschenko

electronic resource

View item; View item; View item

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE

B. B. Gegenava, O. M. Drapkina

electronic resource

View item; View item; View item

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)

R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. Veldhuisen van, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt

electronic resource

View item; View item; View item

Clinical application of mineralocorticoid receptor antagonists in chronic heart failure

MG Bubnova

electronic resource

View item; View item; View item

Primary idiopathic hyperaldosteronism in clinical practice

electronic resource

View item; View item; View item

This result is not displayed to guests.
Login for full access.